Kawasaki, Japan

Tokihiro Tanaka

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Chiba University, Nof Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tokihiro Tanaka. Retrieved from https://idiyas.com/inventor/tokihiro-tanaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tokihiro Tanaka: Innovator in Nucleic Acid Delivery Systems

Introduction

Tokihiro Tanaka is a prominent inventor based in Kawasaki, Japan. He is known for his significant contributions to the field of nucleic acid delivery systems. His innovative work has led to the development of a cationic lipid that enhances the efficiency of nucleic acid introduction into cells.

Latest Patents

Tanaka holds a patent for a cationic lipid having a disulfide bond, which is integral to a lipid membrane structure. This invention includes a nucleic acid introduction agent and a pharmaceutical composition that utilizes the cationic lipid. The patent outlines methods for introducing nucleic acid into target cells and producing cellular pharmaceuticals. This cationic lipid serves as an effective carrier for nucleic acids, demonstrating excellent intracellular dynamics.

Career Highlights

Throughout his career, Tokihiro Tanaka has worked with notable organizations, including Nof Corporation and Chiba University. His experience in these institutions has contributed to his expertise in the field of biochemistry and pharmaceutical sciences.

Collaborations

Tanaka has collaborated with esteemed colleagues such as Masamichi Tamada and Shinya Tamagawa. Their joint efforts have further advanced research in nucleic acid delivery systems.

Conclusion

Tokihiro Tanaka's innovative work in developing cationic lipids for nucleic acid delivery has made a significant impact in the field of pharmaceuticals. His contributions continue to influence advancements in cellular medicine and biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…